Valuation: Medico Intercontinental Limited

Market Cap 244M 2.54M 2.23M 2.11M 1.92M 3.59M 3.62M 25.22M 9.77M 125M 9.55M 9.34M 400M P/E 2025
7.01x
P/E 2026 -7.97x
Enterprise Value 855M 8.92M 7.83M 7.4M 6.74M 12.62M 12.71M 88.5M 34.28M 437M 33.51M 32.78M 1.4B EV / Sales 2025
0.52x
EV / Sales 2026 1.02x
Free-Float
38.75%
Yield 2025 *
-
Yield 2026 -
08-14 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-22 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/08/25 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
14/07/25 Medico Intercontinental Limited Approves the Appointment of Puneeta Sharma as Company Secretary and Compliance Officer, Effective from 14 July, 2025 CI
31/05/25 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
22/04/25 Medico Intercontinental Limited Announces Resignation of Puneeta Sharma as Company Secretary & Compliance Officer, Effective 22 April, 2025 CI
14/11/24 Medico Intercontinental Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
25/05/24 Medico Intercontinental Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
25/05/24 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
25/04/24 Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director CI
09/04/24 Medico Intercontinental Limited Proposes to Incorporate Joint Venture Partnership Firm CI
1 day+3.26%
1 week-8.00%
Current month-10.31%
1 month-13.40%
3 months-16.60%
6 months-13.03%
Current year-39.08%
1 week 23
Extreme 23
26.99
1 month 22.4
Extreme 22.4
29.75
Current year 20.61
Extreme 20.61
42.9
1 year 20.61
Extreme 20.61
43
3 years 20.61
Extreme 20.61
122
5 years 20.61
Extreme 20.61
122
10 years 8
Extreme 8
132.1
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 12/08/2019
Compliance Officer - 01/06/2019
Director TitleAgeSince
Chairman - 08/04/2019
Director/Board Member 53 23/03/2019
Director/Board Member - 14/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
+3.26%-8.00%-32.66%-69.14% 2.54M
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average +0.21%-0.65%+8.67%+59.20% 14.33B
Weighted average by Cap. +0.32%+0.54%+19.51%+79.15%

Financials

2025 2026
Net sales 963M 10.05M 8.81M 8.32M 7.59M 14.2M 14.3M 99.62M 38.58M 492M 37.71M 36.9M 1.58B 846M 8.83M 7.75M 7.32M 6.67M 12.48M 12.57M 87.55M 33.91M 432M 33.14M 32.43M 1.39B
Net income 50.57M 528K 463K 437K 399K 746K 751K 5.23M 2.03M 25.84M 1.98M 1.94M 83.04M -32.01M -334K -293K -277K -252K -472K -476K -3.31M -1.28M -16.35M -1.25M -1.23M -52.55M
Net Debt 142M 1.49M 1.3M 1.23M 1.12M 2.1M 2.11M 14.73M 5.7M 72.72M 5.58M 5.46M 234M 612M 6.38M 5.6M 5.29M 4.82M 9.02M 9.09M 63.29M 24.51M 312M 23.96M 23.44M 1B
Logo Medico Intercontinental Limited
Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.
Employees
41
Date Price Change Volume
25/09/26 ₹24.37 +3.26% 1,557
24/09/26 ₹23.60 -6.16% 627
23/09/26 ₹25.15 +0.72% 1,198
22/09/26 ₹24.97 -1.81% 1,207
21/09/26 ₹25.43 -4.00% 611
  1. Stock Market
  2. Stocks
  3. ICLF Stock